Today’s AI Top Pick: KVYO

8/26/2026 · Highly Shorted High Growth Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Highly Shorted High Growth Deep RotationKVYOBUY NOW8.6 / 108/26/2026

Klaviyo (KVYO) is the cleanest multi-timeframe setup in this pool that isn't already extended to the top of its range. The 4h forecast stack is +28.07% / +47.45% / +36.26% (short/mid/long), the daily is +0.98% / +9.61% / +29.04%, and the weekly is +5.75% / +17.46% / +47.63% — every horizon on every timeframe points up, with acceleration into the mid/long window rather than a fade. Bullish probability is 1.0 and near_term_bullish is 1.0, so the model is not hedging. Crucially, KVYO is NOT chased. Position-in-21bar range is 82/39/49 across 4h/1d/1wk, with drawdowns of −3.07% / −8.62% / −20.27% from recent highs. That is textbook 'good entry' territory — you're buying a name that has already pulled in, not one hugging its highs. Compare that to PAR (pos 89/93/97) or CELH (100/100/100/100) where you'd be paying up. Fundamentals also confirm the growth-at-a-reasonable-price screen: fwd P/E 16.64, PEG 0.65, sales growth 28.89% Y/Y, EPS growth next year 28.28%, analyst recom 1.26 (Strong Buy), and targetUpsidePct 51.4%. Short float 22.48% adds a squeeze kicker if the tape turns. News flow supports rather than undercuts the thesis: recent SeekingAlpha piece calls out 'Tremendous New Product Momentum,' Q2 earnings call is behind us, and management is out at investor events — no guidance cut, no legal overhang, no dilution headline. Contrast that with UPST (insider CFO selling as company returns to profit), PHAT/ADTN (analyst target cuts), SYM (legal risk), and ABAT (dilution concern) — those all have news that clips a leg off their forecasts. Why TODAY vs waiting: the 1d position at 39% of range with an 8.6% drawdown means you're already getting the pullback. Waiting for another leg down risks missing the forecast window that has 4h short-term +28% baked in. This is BUY_NOW, not BUY_PULLBACK.

Entry zone

$17.40–$17.90 (current $17.70, scale in on any dip to the 4h low near $17.15)

Stop loss

$15.90 (below the 1d drawdown floor and prior weekly support, ~10% risk)

First target

$20.50 (aligns with 4h fc_short ~+28% and clears the 1d range top)

Longer target

$25.00–$26.00 (weekly fc_long +47.6% and analyst target upside 51.4%)

Risks

Trailing P/E of 830 means any growth wobble gets punished hard — fwd P/E 16.64 assumes the EPS ramp lands
Short float 22.48% is a squeeze tailwind but also a bearish institutional vote — if 1d closes below $16, the thesis is broken
Operating margin still −1.86% and profit margin 0.49% — not yet a clean profitability story
Perf YTD −45.8% and perf Year −44.25% means the stock is in a long downtrend; the forecast is calling a reversal, not continuation
Broader software/tech tape rotation could stall the setup even with clean company-level signals

Honorable mentions

FOURWells Fargo upgrade this week, fwd P/E 7.52 / PEG 0.54 is the cheapest quality name in the pool, sales growth 32.44%, near_term_bullish 1.0, and pos_in_range 12/48/68 gives room to run. The one blemish: 4h fc_long is −10.22%, suggesting a short-term pop then digestion. Great swing, slightly less clean than KVYO.

PARHighest forecast magnitudes in the pool (1d fc_long +107.84%, 1wk fc_long +110.03%) with prob 1.0 and near_term_bullish 1.0, plus PEG 0.08 and fwd P/E 13.56. Downgraded to #3 only because pos_in_range 89/93/97 is chase territory — better as BUY_PULLBACK into $17–$18.

Full ranking (15)

#	Symbol	Verdict	Score	Read
1	KVYO	BUY NOW	8.6	Every timeframe up, mid-range entry, prob 1.0, product-momentum news — cleanest setup here.
2	FOUR	BUY NOW	8.2	Wells Fargo upgrade + cheapest fwd P/E (7.52) with 1d/1wk forecasts of +25%/+45% into long horizon.
3	PAR	BUY PULLBACK	7.8	Monster forecast (+107% 1d long) but pos 97 on 1wk — wait for a dip to $17s.
4	TMDX	BUY PULLBACK	7.2	Strong 4h/1d forecasts, positive $2B kidney opportunity news, but pos 97/93 and targetUpside only 4%.
5	CRK	BUY PULLBACK	6.8	Prob 1.0 and 4h fc_mid +70%, but 1wk forecasts turn negative and price at 100% of daily range.
6	MNDY	BUY PULLBACK	6.5	1d/1wk forecasts great (+61.9% long) but 1h/4h short-term fade and 1wk pos 96 — wait for pullback.
7	ADTN	BUY PULLBACK	6.2	Deep discount (pos 3–31%) with EPS growth 101%, but Q2 headwinds and analyst cuts argue for patience.
8	UPST	WAIT	5.8	Prob 1.0 and 1d fc_mid +32%, but CFO insider selling and short-term 1d fc negative — mixed signals.
9	SYM	WAIT	5.5	4h/1d bullish but 1wk fc_long −32.14% and legal risks flagged in news.
10	PHAT	BUY PULLBACK	5.3	144% target upside and huge 4h forecast, but Barclays cut PT and 1wk near lows — needs base.
11	BROS	WAIT	5.0	Prob 1.0 and pullback setup, but 1wk forecasts all negative (−7 to −14%) undercuts the case.
12	ABAT	WAIT	4.8	4h forecast +46/+45/+55 but recent dilution headline and 1wk fc_short −18% — narrative fragile.
13	CELH	AVOID	4.5	At 100% of range on all 4 timeframes with negative 1h/4h forecasts — pure chase.
14	RARE	WAIT	4.3	FDA approval catalyst is real but prob only 0.2 and profitability is a live question.
15	DUOL	AVOID	3.2	Prob 0.2, near_term_bullish 0, all short-term forecasts negative, targetUpside −13%.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord